Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-5 of 5
Keywords: Type 2 diabetes
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Mohamed Hassanein, Abdulqawi Almansari, Ebtesam Ba-Essa, Fatheya F. Alawadi, Hussein ElBadawi, Rakesh Kumar Sahay, Rayaz Malik, Rohana Abdul Ghani, Salah Abusnana, Shehla Shaikh, Sueziani Binte Zainudin, Tarik Elhadd, Yousef AL Saleh
Dubai Diabetes Endocrinol J (2022) 28 (4): 131–135.
Published Online: 21 December 2022
... (GLP-1RAs) are proven to be well tolerated and efficacious in people with type 2 diabetes mellitus (T2DM) fasting during Ramadan. The first oral GLP-1RA semaglutide, also indicated for the treatment of T2DM, has specific dosing instructions to optimize treatment exposure, which may need to be altered...
Journal Articles
Ahmed Hassoun, Denish Kumar Dhanwal, Jalal Nafach, Yasmin Ajaz, Asif Majid Khan, Abdullah Ben Nakhi, Monira AlArouj, Khadija Hafidh, Majdi AlNajjar, Ahmed Reyas, Sana Qamar, Mohamed Alsayed, Ahmad Bdair
Dubai Diabetes Endocrinol J (2022) 28 (1): 25–34.
Published Online: 17 January 2022
...), lipid profile, and BPs in patients receiving dapagliflozin with other antidiabetic medication. Methods: The REWARD study was a multicenter, post-authorization, prospective, open-label, noninterventional, real-world, cohort study. We enrolled 511 adult, type 2 diabetes mellitus patients on antidiabetic...
Journal Articles
Dubai Diabetes Endocrinol J (2021) 27 (4): 150–157.
Published Online: 31 August 2021
...) for the baseline risk-assessment of NAFLD in patients with type 2 diabetes mellitus (T2DM). Methods: An observational, cross-sectional, open label, study of investigator-rated NINS was conducted ensuring adherence to relevant ethical standards. Results: In a 3-month period, 29 patients with T2DM were enrolled (age...
Journal Articles
Dubai Diabetes Endocrinol J (2020) 26 (1): 38–43.
Published Online: 09 September 2020
..., instructions or products referred to in the content or advertisements. 2020 Effectiveness Real world Safety Screening of patients SGLT2 inhibitor Type 2 diabetes Diabetes mellitus is enjoying an epidemic state around the world, mainly in countries like India. The global diabetes prevalence...
Journal Articles
Emirates Diabetes Society Consensus Guidelines for the Management of Type 2 Diabetes Mellitus – 2020
Fatheya Alawadi, Salah Abusnana, Bachar Afandi, Khaled M. Aldahmani, Omniyat Alhajeri, Khaled Aljaberi, Juma Alkaabi, Abdulrazzaq Almadani, Alaaeldin Bashier, Salem A. Beshyah, Buthaina bin Belaila, Mohammad Fargaly, Muhammad H. Farooqi, Khadija Hafidh, Mohamed Hassanein, Ahmed Hassoun, Abdul Jabbar, Iyad Ksseiry, Huda E. Mustafa, Hussein Saadi, Sara Suliman
Dubai Diabetes Endocrinol J (2020) 26 (1): 1–20.
Published Online: 19 February 2020
... the screening, diagnosis and management of type 2 diabetes mellitus in adults including individuals at risk of developing the disease. 12 02 2020 14 02 2020 19 02 2020 © 2020 The Author(s) Published by S. Karger AG, Basel Open Access License / Drug Dosage / Disclaimer This article...